Simplex Trading’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-154
Closed -$18.2K – 10638
2020
Q4
$18K Sell
154
-2,056
-93% -$239K ﹤0.01% 7061
2020
Q3
$245K Buy
+2,210
New +$237K ﹤0.01% 3855
2020
Q2
– Sell
-700
Closed -$74.9K – 8864
2020
Q1
$75K Buy
+700
New +$80.4K ﹤0.01% 4698
2019
Q1
– Sell
-2,480
Closed -$203K – 8415
2018
Q4
$188K Sell
2,480
-6,528
-72% -$480K ﹤0.01% 3222
2018
Q3
$720K Buy
9,008
+3,831
+74% +$357K ﹤0.01% 2228
2018
Q2
$514K Buy
5,177
+5,175
+258,750% +$447K ﹤0.01% 2430
2018
Q1
$0 Buy
+2
New +$162 ﹤0.01% 7503
2017
Q4
– Sell
-1,781
Closed -$148K – 7305
2017
Q3
$164K Buy
+1,781
New +$171K 0.01% 1337
2017
Q1
– Sell
-2,956
Closed -$316K – 7272
2016
Q4
$317K Sell
2,956
-32,553
-92% -$3.81M 0.02% 780
2016
Q3
$4.42M Buy
35,509
+12,255
+53% +$1.45M 0.3% 53
2016
Q2
$2.47M Buy
23,254
+17,183
+283% +$2M 0.17% 106
2016
Q1
$695K Buy
6,071
+3,626
+148% +$425K 0.06% 320
2015
Q4
$348K Buy
2,445
+1,663
+213% +$192K 0.03% 576
2015
Q3
$70K Buy
+782
New +$82.5K 0.01% 1732

Other funds holding CBPO

Simplex Trading's CBPO Position: Q1 2021 in Review

Simplex Trading sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2021, closing a stake of 154 shares — an estimated $18.2K sold.

Simplex Trading first reported a position in CBPO in Q3 2015 and held it in 14 quarters. The position peaked at $4.42M in Q3 2016. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.

  • Simplex Trading reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
  • Simplex Trading sold 154 China Biologic Products Holdings, Inc. shares in Q1 2021, an estimated $18.2K.
  • Simplex Trading first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 14 quarters.
  • Simplex Trading's China Biologic Products Holdings, Inc. position peaked at $4.42M in Q3 2016.
  • 86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.

Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.